Partial cystectomy in the treatment of invasive bladder cancer

Tomoyasu Tsushima, Takanori Murakami, Shin Ebara, Nobuyuki Kusaka, Shunko Kaku, Yoshiyuki Miyaji, Yasuo Yamamoto, Yasutomo Nasu, Hiromi Kumon, Hiroyuki Ohmori

Research output: Contribution to journalArticle

Abstract

Forty-eight patients with localized muscle-invasive bladder cancer underwent partial cystectomy. Their median age was 70 years. Of these patients, 67% had G3 tumors, and 40% had stage pT3b or pT4 tumors. Nine patients received neoadjuvant therapy. Thirty-one patients received adjuvant chemotherapy and 21 received postoperative radiotherapy, among whom 19 received adjuvant chemo-radiotherapy. The median follow-up was 38 months for all patients, and 68 months for the surviving patients. The cause-specific 5- year survival rate was 63%, while the non-recurrence 5-year survival rate was 58%. Univariate analysis of prognostic factors was carried out with regard to cause-specific survival. Prognosis was statistically better in patients with tumors less than 2cm in diameter, in those with stages pT2 and 3a disease, and in those without hydronephrosis. Partial cystectomy can be recommended in certain clearly selected patients with localized muscle-invasive bladder cancer.

Original languageEnglish
Pages (from-to)397-401
Number of pages5
JournalNishinihon Journal of Urology
Volume60
Issue number5
Publication statusPublished - May 1998

Fingerprint

Cystectomy
Urinary Bladder Neoplasms
Therapeutics
Survival Rate
Muscles
Neoplasms
Adjuvant Radiotherapy
Neoadjuvant Therapy
Hydronephrosis
Adjuvant Chemotherapy
Radiotherapy
Survival

Keywords

  • Invasive bladder cancer
  • Partial cystectomy

ASJC Scopus subject areas

  • Urology

Cite this

Tsushima, T., Murakami, T., Ebara, S., Kusaka, N., Kaku, S., Miyaji, Y., ... Ohmori, H. (1998). Partial cystectomy in the treatment of invasive bladder cancer. Nishinihon Journal of Urology, 60(5), 397-401.

Partial cystectomy in the treatment of invasive bladder cancer. / Tsushima, Tomoyasu; Murakami, Takanori; Ebara, Shin; Kusaka, Nobuyuki; Kaku, Shunko; Miyaji, Yoshiyuki; Yamamoto, Yasuo; Nasu, Yasutomo; Kumon, Hiromi; Ohmori, Hiroyuki.

In: Nishinihon Journal of Urology, Vol. 60, No. 5, 05.1998, p. 397-401.

Research output: Contribution to journalArticle

Tsushima, T, Murakami, T, Ebara, S, Kusaka, N, Kaku, S, Miyaji, Y, Yamamoto, Y, Nasu, Y, Kumon, H & Ohmori, H 1998, 'Partial cystectomy in the treatment of invasive bladder cancer', Nishinihon Journal of Urology, vol. 60, no. 5, pp. 397-401.
Tsushima T, Murakami T, Ebara S, Kusaka N, Kaku S, Miyaji Y et al. Partial cystectomy in the treatment of invasive bladder cancer. Nishinihon Journal of Urology. 1998 May;60(5):397-401.
Tsushima, Tomoyasu ; Murakami, Takanori ; Ebara, Shin ; Kusaka, Nobuyuki ; Kaku, Shunko ; Miyaji, Yoshiyuki ; Yamamoto, Yasuo ; Nasu, Yasutomo ; Kumon, Hiromi ; Ohmori, Hiroyuki. / Partial cystectomy in the treatment of invasive bladder cancer. In: Nishinihon Journal of Urology. 1998 ; Vol. 60, No. 5. pp. 397-401.
@article{a7428d79ebd346bf956965a37f580bf0,
title = "Partial cystectomy in the treatment of invasive bladder cancer",
abstract = "Forty-eight patients with localized muscle-invasive bladder cancer underwent partial cystectomy. Their median age was 70 years. Of these patients, 67{\%} had G3 tumors, and 40{\%} had stage pT3b or pT4 tumors. Nine patients received neoadjuvant therapy. Thirty-one patients received adjuvant chemotherapy and 21 received postoperative radiotherapy, among whom 19 received adjuvant chemo-radiotherapy. The median follow-up was 38 months for all patients, and 68 months for the surviving patients. The cause-specific 5- year survival rate was 63{\%}, while the non-recurrence 5-year survival rate was 58{\%}. Univariate analysis of prognostic factors was carried out with regard to cause-specific survival. Prognosis was statistically better in patients with tumors less than 2cm in diameter, in those with stages pT2 and 3a disease, and in those without hydronephrosis. Partial cystectomy can be recommended in certain clearly selected patients with localized muscle-invasive bladder cancer.",
keywords = "Invasive bladder cancer, Partial cystectomy",
author = "Tomoyasu Tsushima and Takanori Murakami and Shin Ebara and Nobuyuki Kusaka and Shunko Kaku and Yoshiyuki Miyaji and Yasuo Yamamoto and Yasutomo Nasu and Hiromi Kumon and Hiroyuki Ohmori",
year = "1998",
month = "5",
language = "English",
volume = "60",
pages = "397--401",
journal = "Nishinihon Journal of Urology",
issn = "0029-0726",
publisher = "Kyushu University, Faculty of Science",
number = "5",

}

TY - JOUR

T1 - Partial cystectomy in the treatment of invasive bladder cancer

AU - Tsushima, Tomoyasu

AU - Murakami, Takanori

AU - Ebara, Shin

AU - Kusaka, Nobuyuki

AU - Kaku, Shunko

AU - Miyaji, Yoshiyuki

AU - Yamamoto, Yasuo

AU - Nasu, Yasutomo

AU - Kumon, Hiromi

AU - Ohmori, Hiroyuki

PY - 1998/5

Y1 - 1998/5

N2 - Forty-eight patients with localized muscle-invasive bladder cancer underwent partial cystectomy. Their median age was 70 years. Of these patients, 67% had G3 tumors, and 40% had stage pT3b or pT4 tumors. Nine patients received neoadjuvant therapy. Thirty-one patients received adjuvant chemotherapy and 21 received postoperative radiotherapy, among whom 19 received adjuvant chemo-radiotherapy. The median follow-up was 38 months for all patients, and 68 months for the surviving patients. The cause-specific 5- year survival rate was 63%, while the non-recurrence 5-year survival rate was 58%. Univariate analysis of prognostic factors was carried out with regard to cause-specific survival. Prognosis was statistically better in patients with tumors less than 2cm in diameter, in those with stages pT2 and 3a disease, and in those without hydronephrosis. Partial cystectomy can be recommended in certain clearly selected patients with localized muscle-invasive bladder cancer.

AB - Forty-eight patients with localized muscle-invasive bladder cancer underwent partial cystectomy. Their median age was 70 years. Of these patients, 67% had G3 tumors, and 40% had stage pT3b or pT4 tumors. Nine patients received neoadjuvant therapy. Thirty-one patients received adjuvant chemotherapy and 21 received postoperative radiotherapy, among whom 19 received adjuvant chemo-radiotherapy. The median follow-up was 38 months for all patients, and 68 months for the surviving patients. The cause-specific 5- year survival rate was 63%, while the non-recurrence 5-year survival rate was 58%. Univariate analysis of prognostic factors was carried out with regard to cause-specific survival. Prognosis was statistically better in patients with tumors less than 2cm in diameter, in those with stages pT2 and 3a disease, and in those without hydronephrosis. Partial cystectomy can be recommended in certain clearly selected patients with localized muscle-invasive bladder cancer.

KW - Invasive bladder cancer

KW - Partial cystectomy

UR - http://www.scopus.com/inward/record.url?scp=7144257834&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=7144257834&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:7144257834

VL - 60

SP - 397

EP - 401

JO - Nishinihon Journal of Urology

JF - Nishinihon Journal of Urology

SN - 0029-0726

IS - 5

ER -